Publicação
Role of adenosine in epilepsy and seizures
| dc.contributor.author | Tescarollo, Fabio C. | |
| dc.contributor.author | Rombo, Diogo M. | |
| dc.contributor.author | DeLiberto, Lindsay K. | |
| dc.contributor.author | Fedele, Denise E. | |
| dc.contributor.author | Alharfoush, Enmar | |
| dc.contributor.author | Tomé, Ângelo R. | |
| dc.contributor.author | Cunha, Rodrigo A. | |
| dc.contributor.author | Sebastião, Ana M | |
| dc.contributor.author | Boison, Detlev | |
| dc.date.accessioned | 2021-02-18T16:24:47Z | |
| dc.date.available | 2021-02-18T16:24:47Z | |
| dc.date.issued | 2020 | |
| dc.description | © Mary Ann Liebert, Inc. | pt_PT |
| dc.description.abstract | Adenosine is an endogenous anticonvulsant and neuroprotectant of the brain. Seizure activity produces large quantities of adenosine, and it is this seizure-induced adenosine surge that normally stops a seizure. However, within the context of epilepsy, adenosine plays a wide spectrum of different roles. It not only controls seizures (ictogenesis), but also plays a major role in processes that turn a normal brain into an epileptic brain (epileptogenesis). It is involved in the control of abnormal synaptic plasticity and neurodegeneration and plays a major role in the expression of comorbid symptoms and complications of epilepsy, such as sudden unexpected death in epilepsy (SUDEP). Given the important role of adenosine in epilepsy, therapeutic strategies are in development with the goal to utilize adenosine augmentation not only for the suppression of seizures but also for disease modification and epilepsy prevention, as well as strategies to block adenosine A2A receptor overfunction associated with neurodegeneration. This review provides a comprehensive overview of the role of adenosine in epilepsy. | pt_PT |
| dc.description.sponsorship | The authors acknowledge grant support from the National Institutes of Health to D.B. (NINDS: NS103740, NS065957); support to A.M.S. by LISBOA-01-0145-FEDER-007391, project cofunded by Fundo Europeu Para o Desenvolvimento Regional through POR Lisboa 2020 (Programa Operacional Regional de Lisboa) from PORTUGAL 2020 and Fundação para a Ciência e Tecnologia (FCT), by an FCT project (PTDC/MED-FAR/30933/2017) and by Twinning action (SynaNet) from the EU H2020 programme (project number: 692340); and support to R.A.C. and A.R.T. by Fundacion LaCaixa (LCF/PR/HP17/52190001), Centro 2020 (CENTRO-01-0145-FEDER-000008: BrainHealth 2020 and CENTRO-01-0246-FEDER-000010) and FCT (POCI-01-0145-FEDER-03127). | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | J Caffeine Adenosine Res. 2020 Jun 1;10(2):45-60 | pt_PT |
| dc.identifier.doi | 10.1089/caff.2019.0022 | pt_PT |
| dc.identifier.eissn | 2573-3400 | |
| dc.identifier.issn | 2573-3397 | |
| dc.identifier.uri | http://hdl.handle.net/10451/46426 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Mary Ann Liebert, Inc. | pt_PT |
| dc.relation | LISBOA-01-0145-FEDER-007391 | pt_PT |
| dc.relation | NS103740 | pt_PT |
| dc.relation | NS065957 | pt_PT |
| dc.relation | In the search of the synaptic mechanism operated by a novel selective antiepileptic drug | |
| dc.relation | Neurologic and Psychiatric Disorders: from synapses to networks | |
| dc.relation | CENTRO-01-0145-FEDER-000008 | pt_PT |
| dc.relation | CENTRO-01-0246-FEDER-000010 | pt_PT |
| dc.relation | POCI-01-0145-FEDER-03127 | pt_PT |
| dc.relation.publisherversion | https://home.liebertpub.com/publications/journal-of-caffeine-and-adenosine-research/388/ | pt_PT |
| dc.subject | Adenosine | pt_PT |
| dc.subject | Adenosine receptors | pt_PT |
| dc.subject | Adenosine kinase | pt_PT |
| dc.subject | Epilepsy | pt_PT |
| dc.subject | Seizure | pt_PT |
| dc.subject | Epileptogenesis | pt_PT |
| dc.title | Role of adenosine in epilepsy and seizures | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | In the search of the synaptic mechanism operated by a novel selective antiepileptic drug | |
| oaire.awardTitle | Neurologic and Psychiatric Disorders: from synapses to networks | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FMED-FAR%2F30933%2F2017/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/EC/H2020/692340/EU | |
| oaire.citation.endPage | 60 | pt_PT |
| oaire.citation.issue | 2 | pt_PT |
| oaire.citation.startPage | 45 | pt_PT |
| oaire.citation.title | Journal of Caffeine and Adenosine Research | pt_PT |
| oaire.citation.volume | 10 | pt_PT |
| oaire.fundingStream | 3599-PPCDT | |
| oaire.fundingStream | H2020 | |
| person.familyName | Rombo | |
| person.familyName | Sebastião | |
| person.givenName | Diogo | |
| person.givenName | Ana M | |
| person.identifier.ciencia-id | F112-55E8-E37E | |
| person.identifier.orcid | 0000-0002-9922-7381 | |
| person.identifier.orcid | 0000-0001-9030-6115 | |
| person.identifier.scopus-author-id | 7004409879 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100008530 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | European Commission | |
| rcaap.rights | restrictedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 8814f5da-e3f7-4b74-af11-09616eecdee1 | |
| relation.isAuthorOfPublication | 304abd7f-071b-4447-a8a3-4aa5f0547141 | |
| relation.isAuthorOfPublication.latestForDiscovery | 8814f5da-e3f7-4b74-af11-09616eecdee1 | |
| relation.isProjectOfPublication | 7027027e-87f3-442e-9bdc-9fadad40a229 | |
| relation.isProjectOfPublication | a8d0a09b-e946-45d0-ac79-0b6e4fff9e49 | |
| relation.isProjectOfPublication.latestForDiscovery | a8d0a09b-e946-45d0-ac79-0b6e4fff9e49 |
Ficheiros
Principais
1 - 1 de 1
Miniatura indisponível
- Nome:
- Role_adenosine.pdf
- Tamanho:
- 406.56 KB
- Formato:
- Adobe Portable Document Format
